23 related articles for article (PubMed ID: 16981227)
1. Influence of CYP2C19 and CYP2D6 on side effects of aripiprazole and risperidone: A systematic review.
de Brabander E; Kleine Schaars K; van Amelsvoort T; ; van Westrhenen R
J Psychiatr Res; 2024 Jun; 174():137-152. PubMed ID: 38631139
[TBL] [Abstract][Full Text] [Related]
2. D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis.
Zhang JP; Lencz T; Malhotra AK
Am J Psychiatry; 2010 Jul; 167(7):763-72. PubMed ID: 20194480
[TBL] [Abstract][Full Text] [Related]
3. Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients.
Shen YC; Chen SF; Chen CH; Lin CC; Chen SJ; Chen YJ; Luu SU
J Psychiatr Res; 2009 Mar; 43(6):600-6. PubMed ID: 18926547
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of aripiprazole, a new antipsychotic, following oral dosing in healthy adult Japanese volunteers: influence of CYP2D6 polymorphism.
Kubo M; Koue T; Maune H; Fukuda T; Azuma J
Drug Metab Pharmacokinet; 2007 Oct; 22(5):358-66. PubMed ID: 17965519
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Resting State Electroencephalography in Patients with Schizophrenia Spectrum Disorders Treated with Strict Monotherapy Using Atypical Antipsychotics.
Ozaki T; Toyomaki A; Hashimoto N; Kusumi I
Clin Psychopharmacol Neurosci; 2021 May; 19(2):313-322. PubMed ID: 33888660
[TBL] [Abstract][Full Text] [Related]
6. ASD: Psychopharmacologic Treatments and Neurophysiologic Underpinnings.
Kodish I; Rockhill CM; Webb SJ
Curr Top Behav Neurosci; 2014; 21():257-75. PubMed ID: 24683058
[TBL] [Abstract][Full Text] [Related]
7. Electroencephalogram-based pharmacodynamic measures: a review.
Bewernitz M; Derendorf H
Int J Clin Pharmacol Ther; 2012 Mar; 50(3):162-84. PubMed ID: 22373830
[TBL] [Abstract][Full Text] [Related]
8. [Clinical pharmacogenetics in the treatment of schizophrenia].
Saito M; Yasui-Furukori N; Kaneko S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Jun; 25(3):129-35. PubMed ID: 16045195
[TBL] [Abstract][Full Text] [Related]
9. Effects of DRD2 and CYP2D6 genotypes on delta EEG power response to aripiprazole in healthy male volunteers: a preliminary study.
Kim E; Yu KS; Cho JY; Shin YW; Yoo SY; Kim YY; Jang IJ; Shin SG; Kwon JS
Hum Psychopharmacol; 2006 Dec; 21(8):519-28. PubMed ID: 16981227
[TBL] [Abstract][Full Text] [Related]
10. CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine.
Aklillu E; Kalow W; Endrenyi L; Harper P; Miura J; Ozdemir V
Pharmacogenet Genomics; 2007 Nov; 17(11):989-93. PubMed ID: 18075468
[TBL] [Abstract][Full Text] [Related]
11. Prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of dopamine D2 receptor and cytochrome P450 2D6 in Japanese patients with schizophrenia.
Nagai G; Mihara K; Nakamura A; Suzuki T; Nemoto K; Kagawa S; Ohta I; Arakaki H; Kondo T
Psychiatry Clin Neurosci; 2012 Oct; 66(6):518-24. PubMed ID: 23066770
[TBL] [Abstract][Full Text] [Related]
12. Taq1A polymorphism in the dopamine D2 receptor gene predicts brain metabolic response to aripiprazole in healthy male volunteers.
Kim E; Kwon JS; Shin YW; Lee JS; Kang WJ; Jo HJ; Lee JM; Yu KS; Kang DH; Cho JY; Jang IJ; Shin SG
Pharmacogenet Genomics; 2008 Feb; 18(2):91-7. PubMed ID: 18192895
[TBL] [Abstract][Full Text] [Related]
13. Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia.
Miura I; Takeuchi S; Katsumi A; Mori A; Kanno K; Yang Q; Mashiko H; Numata Y; Niwa S
J Clin Psychopharmacol; 2012 Feb; 32(1):106-9. PubMed ID: 22198450
[TBL] [Abstract][Full Text] [Related]
14. The effect of the Taq1A variant in the dopamine Dâ‚‚ receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys.
Roke Y; van Harten PN; Franke B; Galesloot TE; Boot AM; Buitelaar JK
Pharmacogenet Genomics; 2013 Sep; 23(9):487-93. PubMed ID: 23851570
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
